Evidence map›Paper›PMID 20698576›Full record

ArticleMolecular pharmaceutics2010

Transport and metabolism of radiolabeled choline in hepatocellular carcinoma.

Yu Kuang, Nicolas Salem, David J Corn, Bernadette Erokwu, Haibin Tian, Fangjing Wang, Zhenghong Lee

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. PET Imaging of Hepatocellular Carcinoma Using ZD2-(Journal of hepatocellular carcinoma · 2023
    Article
  7. Article
  8. Nerve regeneration in transplanted organs and tracer imaging studies: A review.Frontiers in bioengineering and biotechnology · 2022
    Review
  9. FusedRadiology case reports · 2021
    Article
  10. Review
  11. Article
  12. Article
  13. Liver background uptake of [American journal of nuclear medicine and molecular imaging · 2020
    Article
  14. Article
  15. Article
  16. [Translational cancer research · 2016
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yu KuangDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Nicolas Salem
David J Corn
Bernadette Erokwu
Haibin Tian
Fangjing Wang
Zhenghong Lee
Case Western Reserve University · USUniversity Hospitals of Cleveland · USUniversity Hospitals Case Medical Center · US

Funding

Interdisciplinary Biomedical Imaging Training ProgramT32EB007509 · NIBIB · CASE WESTERN RESERVE UNIVERSITY · PI DAVID Lynn WILSON, Xin Yu · 2007 to 2026
$5.6M
Quantitative FDG-PET for Imaging Woodchuck HCCR01CA095307 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI LEE, ZHENGHONG · 2003 to 2013
$3.5M
NCI NIH HHS R01 CA095307NIBIB NIH HHS T32 EB007509
6 · The paper itself

Abstract

Altered choline (Cho) metabolism in cancerous cells can be used as a basis for molecular imaging with PET using radiolabeled Cho. In this study, the metabolism of tracer Cho was investigated in a woodchuck hepatocellular carcinoma (HCC) cell line (WCH17) and in freshly derived rat hepatocytes. The transporter responsible for [(11)C]-Cho uptake in HCC was also characterized in WCH17 cells. The study helped to define the specific mechanisms responsible for radio-Cho uptake seen on the PET images of primary liver cancer such as HCC. Cells were pulsed with [(14)C]-Cho for 5 min and chased for varying durations in cold media to simulate the rapid circulation and clearance of [(11)C]-Cho. Radioactive metabolites were extracted and analyzed by radio-HPLC and radio-TLC. The Cho transporter (ChoT) was characterized in WCH17 cells. WCH17 cells showed higher (14)C uptake than rat primary hepatocytes. [(14)C]-Phosphocholine (PC) was the major metabolite in WCH17. In contrast, the intracellular Cho in primary hepatocytes was found to be oxidized to betaine (partially released into media) and, to a lesser degree, phosphorylated to PC. [(14)C]-Cho uptake by WCH17 cells was found to have both facilitative transport and nonfacilitative diffusion components. The facilitative transport was characterized by Na(+) dependence and low affinity (K(m) = 28.59 ± 6.75 μM) with partial energy dependence. In contrast, ChoT in primary hepatocytes is Na(+) independent and low affinity. Our data suggest that transport and phosphorylation of Cho are responsible for the tracer accumulation during [(11)C]-Cho PET imaging of HCC. WCH17 cells incorporate [(14)C]-Cho preferentially into PC. Conversion of [(14)C]-PC into phosphatidylcholine occurred slowly in vitro. Basal oxidation and phosphorylation activities in surrounding hepatic tissue contribute to the background seen in [(11)C]-Cho PET images.

Indexed as

AnimalsCarbon RadioisotopesCarcinoma, HepatocellularCells, CulturedCholineDinitrophenolsHemicholinium 3KineticsLiver NeoplasmsMembrane Transport ProteinsOuabainPositron-Emission TomographyRatsStructure-Activity RelationshipCarbon RadioisotopesCholinecholine transporterDinitrophenolsHemicholinium 3Membrane Transport ProteinsOuabain

Identifiers

PMID20698576
PMCPMC2992798
OpenAlexW2088135392

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.